Asston Pharmaceuticals EV/EBITDA Ratio

Asston Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio

The Asston Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate Asston Pharmaceuticals Ltd's valuation, profitability, and overall financial performance. Tracking the Asston Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Asston Pharmaceuticals Ltd (NSE: , BSE: 544445) is currently trading at ₹81, with a market capitalization of ₹662.01M. As a leading company in the Distribution services sector and Medical distributors industry, monitoring the Asston Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.

Asston Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio Current Value

The current Asston Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio stands at 0.

The Asston Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio remains stable, indicating consistent financial performance.

Asston Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio Historical Trend

The Asston Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

The decline in Asston Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio indicates improving financial efficiency or better earnings growth.

What Asston Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio Indicates for Investors

The Asston Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.

This ratio is an important metric used in fundamental analysis of Asston Pharmaceuticals Ltd.

Asston Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio Analysis Summary

The Asston Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Asston Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Asston Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.